What's breaking now, across thousands of outlets.
Epicrispr Biotechnologies has raised $90 million for its Series C round after sharing promising early data around a potential new way to treat a rare muscle disease called facioscapulohumeral muscular dystrophy. The Series C was ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
They stress that preventing these diseases requires moving beyond treating patients after they are bitten, to addressing the environmental, animal, and community factors that drive disease…
[Capital FM] Nairobi -- The United States has announced an additional $242 million to support immediate Ebola response, preparedness and humanitarian efforts in countries affected by or at risk from…
[Capital FM] Nairobi -- The United States has announced an additional $242 million to support immediate Ebola response, preparedness and humanitarian efforts in countries affected by or at risk from…
[Independent (Kampala)] The Democratic Republic of Congo needs to urgently expand its community-led response to Ebola as new infections and deaths continue to outpace efforts to contain the outbreak…
Sponsored content brought to you by South Carolina just landed a $1.5 billion investment and more than 1,200 jobs, as Octapharma Plasma relocates its U.S.
The shortage is causing long treatment queues, with doctors suggesting the rise of at-home DNA testing may be making some potential donors think twice.
